Obesity

MedTech

Boston Scientific snatches up gastro-focused Apollo for $615M

Boston Scientific has laid down a deal to acquire the gastrointestinal device company Apollo Endosurgery, with an offer totaling about $615 million.
Conor Hale Nov 29, 2022 12:51pm

Overeating sweet treats? Scientists find what drives this desire

Oct 25, 2022 7:05am

Altimmune hits NASH target in phase 1 trial

Sep 14, 2022 11:45am

Gunning for China's obesity market, LeaderMed targets US IPO

Sep 1, 2022 6:35pm

Novo Nordisk to pilot obesity risk tests with Digbi Health

Aug 22, 2022 11:03am

Boosting fat burning with a blood thinner

Jul 8, 2022 10:00am